Literature DB >> 35256546

Mitral Valve Repair for Barlow's Disease with Mitral Annular and Subvalvular Calcification: A Case Report.

Kosuke Nakamae1, Takashi Oshitomi1, Kentaro Takaji1, Hideyuki Uesugi1.   

Abstract

Barlow's disease with mitral annular calcification encompassing the subvalvular apparatus, including the valve leaflet and chordae, is extremely rare, and mitral valve repair in such cases is challenging. We report a case of a 60-year-old woman with mitral valve regurgitation that was successfully controlled by resecting the rough zone of P2 and calcifications on the excess leaflet regions and subvalvular apparatus, while retaining the calcification of P3 and implanting artificial chordae and an annuloplasty ring. Mitral valve repair for such cases requires an individualized and compounded surgical strategy for the technique to treat Barlow's disease and manage calcification to control mitral regurgitation.

Entities:  

Keywords:  Barlow’s disease; Case report; Decalcification; Heart valve diseases; Mitral valve repair

Year:  2022        PMID: 35256546      PMCID: PMC9005943          DOI: 10.5090/jcs.21.113

Source DB:  PubMed          Journal:  J Chest Surg        ISSN: 2765-1606


Case report

Text Barlow’s disease (BD), which is known to involve leaflet myxoid degeneration (leaflet thickening, large redundant leaflets, chordal elongation or rupture, and annular dilation), sometimes causes mitral regurgitation (MR) [1]. Although some factors correlate with the prevalence of mitral annular calcification (MAC) [2], BD with MAC encompassing the subvalvular apparatus is rare, and surgical strategies for mitral valve repair (MVr) remain unclear. In this case report, we present a case which we successfully controlled mitral valve (MV) regurgitation by resecting the valve leaflet, performing decalcification, and retaining a part of the calcification. A 60-year-old woman was referred to Saiseikai Kumamoto Hospital with dyspnea on exertion. Echocardiography revealed cardiac enlargement, no asynergy of left ventricular wall motion, an ejection fraction (EF) of 65%, severe MR (effective regurgitation orifice area of 0.59 cm2) with bi-leaflet thickening (Fig. 1A), myxomatous changes with excessive tissue formation (Fig. 1B), and billowing with prolapse (Fig. 1C), which are characteristic pathologic changes of BD. Computed tomography (CT) revealed calcification of the mitral annulus, leaflets, and subvalvular apparatus, such as the chordae (Fig. 1D). Our cardiology team recommended surgery based on the severity of MR.
Fig. 1

(A) Preoperative echocardiography reveals severe mitral regurgitation. Bi-leaflet thickening, (B) myxomatous change, and (C) bi-leaflet prolapse (yellow arrow), indicating Barlow’s disease. (D) Preoperative computed tomography reveals calcification of mitral annular and subvalvular apparatus at P2 and P3. Ao, aorta; LA, left atrium; LV, left ventricle; PM, papillary muscle.

Surgical procedure is as follows (Supplementary Video 1). Surgery was performed with the da Vinci surgical system (Intuitive Surgical Inc., Sunnyvale, CA, USA) using 4 chest ports, and cardiopulmonary bypass was initiated using the right femoral artery and vein. Cardiac standstill was obtained from antegrade cardioplegia, and we approached the MV through a right-side left atriotomy. The bi-leaflet of the MV was large and excessively thickened; annular, leaflet, and subvalvular calcifications at P2 and P3 were observed. We resected the rough zone of P2 in a pentagonal shape, and performed decalcification by en bloc resection of the calcium deposits at the leaflet and chordae of P2. The calcification of the P3 leaflet was retained. After suturing the P2 leaflet in an inverted T-shape, we implanted 2 artificial chordae from the bilateral papillary muscles and a 36-mm Physio Flex annuloplasty ring (Edwards Lifesciences, Irvine, CA, USA). MV competence upon normal saline injection was satisfactory. The operative, cardiopulmonary bypass, and cross-clamp times were 359 minutes, 277 minutes, and 200 minutes, respectively. The postoperative course was uneventful. At 1 week postoperatively, echocardiography showed preserved EF (59%), improvement of the left ventricular endo-diastolic diameter from 55 mm preoperatively to 45 mm, with a mean pressure gradient of 2.2 mm Hg, and no residual MR (Fig. 2A). Enhanced CT performed at 1 week postoperatively revealed resection of most calcification in the region of P2, but calcification in P3 were retained (Fig. 2B). At a 1-year follow-up visit, progression of MR and cardiac enlargement were not observed.
Fig. 2

(A) Postoperative transthoracic echocardiography reveals no mitral regurgitation. (B) Postoperative computed tomography reveals that most calcification on P2 was resected, but calcification was retained on P3. LA, left atrium; LV, left ventricle; Ao, aorta.

Our institutional review board made the decision that ethical approval was not needed for this study. Informed consent was obtained from the patient.

Discussion

The prevalence of MAC in patients undergoing MVr is relatively high. Fusini et al. [2] reported that some factors correlated with MAC and that posterior annular involvement was the most common site of MAC. However, Carpentier et al. [3] reported that cases of MAC involving the subvalvular apparatus, such as chordae and papillary muscles, were rare. Therefore, MVr for BD with MAC encompassing the subvalvular apparatus is a challenging procedure, and management of calcifications, the method of MVr, and whether to repair or replace it are the key surgical considerations. Various methods have been previously reported regarding the management of MAC. Carpentier et al. [3] reported en bloc resection and reconstruction of the atrioventricular groove with 2-0 vertical sutures. Loulmet et al. [4] reported the modified patch technique for repairing an atrioventricular groove after en bloc resection of extensive MAC. Residual MAC might limit the leaflet mobility and cause residual MR or postoperative mitral stenosis (MS); however, excessive resection may also cause disruption of the morphology of the MV, which makes it impossible to repair. In this case, calcification involved the leaflet and chordae of P2 and P3, as well as the annulus of P3. P2 calcification contributed to restrained movement of the leaflet and may have caused postoperative MS. Conversely, the P3 calcification involved a smaller area and might not have contributed to postoperative MS; however, its resection may have collapsed the MV morphology. Many reports have investigated the methods of MVr for BD. Ben Zekry et al. [5] analyzed simple repair for BD with only an annuloplasty ring; however, this seems incomplete because it included a certain number of cases that had systolic anterior motion (SAM) of the anterior leaflet. Some reports have suggested a relationship between BD and mitral annular disjunction, and Hiemstra et al. [6] reported annular remodeling and stabilization as being important for the surgical treatment in BD in order to correct the dilation and abnormal annulus movement. Miura et al. [7] reported a restoration technique that involved reducing the lateral volume of excess leaflets in the rough zone and correcting the prolapse using a few artificial chordae. Therefore, we followed the MVr strategy according to these concepts of fixing the MV by annuloplasty, reducing excess volume by resection, and correcting the prolapse with artificial chordae, and we controlled MR without causing residual MR, MS, or SAM. In conclusion, MVr for BD with MAC encompassing the subvalvular apparatus requires careful assessment of the distribution of calcifications, valve morphology, and surgical techniques for managing calcification.

Supplementary materials

Supplementary materials can be found via https://doi.org/10.5090/jcs.21.113. Supplementary Video 1. Intraoperative mitral valve repair technique for Barlow’s disease with mitral annular calcification encompassing the subvalvular apparatus.
  7 in total

1.  Advanced experience allows robotic mitral valve repair in the presence of extensive mitral annular calcification.

Authors:  Didier F Loulmet; Neel K Ranganath; Siyamek Neragi-Miandoab; Michael S Koeckert; Aubrey C Galloway; Eugene A Grossi
Journal:  J Thorac Cardiovasc Surg       Date:  2019-11-02       Impact factor: 5.209

2.  Aneurysmal protrusion of the posterior leaflet of the mitral valve. An auscultatory-electrocardiographic syndrome.

Authors:  J B Barlow; C K Bosman
Journal:  Am Heart J       Date:  1966-02       Impact factor: 4.749

Review 3.  Technical aspects of mitral valve repair in Barlow's valve with prolapse of both leaflets: triangular resection for excess tissue, sophisticated chordal replacement, and their combination (the restoration technique).

Authors:  Takashi Miura; Tsuneo Ariyoshi; Kazuyoshi Tanigawa; Seiji Matsukuma; Shougo Yokose; Mizuki Sumi; Kazuki Hisatomi; Akira Tsuneto; Koji Hashizume; Kiyoyuki Eishi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-11-29

4.  Simple repair approach for mitral regurgitation in Barlow disease.

Authors:  Sagit Ben Zekry; Dan Spiegelstein; Leonid Sternik; Innon Lev; Alexander Kogan; Rafael Kuperstein; Ehud Raanani
Journal:  J Thorac Cardiovasc Surg       Date:  2015-08-13       Impact factor: 5.209

5.  Prevalence of calcification of the mitral valve annulus in patients undergoing surgical repair of mitral valve prolapse.

Authors:  Laura Fusini; Sarah Ghulam Ali; Gloria Tamborini; Manuela Muratori; Paola Gripari; Francesco Maffessanti; Fabrizio Celeste; Marco Guglielmo; Claudia Cefalù; Francesco Alamanni; Marco Zanobini; Mauro Pepi
Journal:  Am J Cardiol       Date:  2014-03-18       Impact factor: 2.778

6.  Extensive calcification of the mitral valve anulus: pathology and surgical management.

Authors:  A F Carpentier; M Pellerin; J F Fuzellier; J Y Relland
Journal:  J Thorac Cardiovasc Surg       Date:  1996-04       Impact factor: 5.209

7.  Evolution from mitral annular dysfunction to severe mitral regurgitation in Barlow's disease.

Authors:  Yasmine L Hiemstra; Anton Tomsic; Paola Gripari; Aniek L van Wijngaarden; Stéphanie L van der Pas; Meindert Palmen; Robert J M Klautz; Mauro Pepi; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.